Panagora Asset Management Inc Heron Therapeutics, Inc. Transaction History

Panagora Asset Management Inc

$20.5 Billion
Q3 2024

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 29, 2024	BUY	$2.32 - $3.86 $433,380 - $721,055	186,802 Added 49.76%	562,228 $1.97 Million
Q1 2024 May 07, 2024	BUY	$1.71 - $3.06 $404,095 - $723,117	236,313 Added 169.87%	375,426 $1.04 Million
Q4 2023 Feb 08, 2024	BUY	$0.54 - $1.82 $75,121 - $253,185	139,113 New	139,113 $236,000
Q4 2022 Feb 13, 2023	BUY	$2.25 - $4.67 $1.03 Million - $2.13 Million	455,889 Added 1830.95%	480,788 $1.2 Million
Q3 2022 Nov 14, 2022	BUY	$2.66 - $5.37 $21,309 - $43,019	8,011 Added 47.44%	24,899 $105,000
Q2 2022 Aug 15, 2022	BUY	$2.3 - $6.29 $7,684 - $21,014	3,341 Added 24.66%	16,888 $47,000
Q1 2022 May 12, 2022	SELL	$4.63 - $9.94 $361,755 - $776,642	-78,133 Reduced 85.22%	13,547 $77,000
Q4 2021 Feb 10, 2022	SELL	$8.35 - $12.6 $3.38 Million - $5.1 Million	-404,603 Reduced 81.53%	91,680 $837,000
Q3 2021 Nov 10, 2021	SELL	$10.13 - $15.0 $1,347 - $1,995	-133 Reduced 0.03%	496,283 $5.31 Million
Q2 2021 Aug 11, 2021	SELL	$13.27 - $18.48 $148,225 - $206,421	-11,170 Reduced 2.2%	496,416 $7.7 Million
Q1 2021 May 12, 2021	SELL	$14.49 - $20.72 $134,264 - $191,991	-9,266 Reduced 1.79%	507,586 $8.23 Million
Q4 2020 Feb 10, 2021	SELL	$14.61 - $22.14 $156,487 - $237,141	-10,711 Reduced 2.03%	516,852 $10.9 Million
Q3 2020 Nov 13, 2020	BUY	$13.67 - $17.77 $1.36 Million - $1.76 Million	99,295 Added 23.19%	527,563 $7.82 Million
Q2 2020 Aug 12, 2020	BUY	$10.89 - $21.47 $1.39 Million - $2.74 Million	127,504 Added 42.39%	428,268 $6.3 Million
Q1 2020 May 14, 2020	BUY	$10.23 - $24.56 $2.15 Million - $5.17 Million	210,384 Added 232.78%	300,764 $3.53 Million
Q4 2019 Feb 12, 2020	SELL	$17.42 - $26.61 $1.84 Million - $2.81 Million	-105,452 Reduced 53.85%	90,380 $2.12 Million
Q3 2019 Nov 12, 2019	SELL	$16.36 - $21.39 $7.43 Million - $9.71 Million	-454,176 Reduced 69.87%	195,832 $3.62 Million
Q2 2019 Aug 09, 2019	BUY	$16.93 - $26.22 $1.41 Million - $2.19 Million	83,352 Added 14.71%	650,008 $12.1 Million
Q1 2019 May 15, 2019	BUY	$23.15 - $28.34 $2.22 Million - $2.71 Million	95,784 Added 20.34%	566,656 $13.8 Million
Q4 2018 Feb 14, 2019	BUY	$22.03 - $32.01 $2.08 Million - $3.02 Million	94,253 Added 25.03%	470,872 $12.2 Million
Q3 2018 Nov 13, 2018	BUY	$30.0 - $40.85 $424,290 - $577,741	14,143 Added 3.9%	376,619 $11.9 Million
Q2 2018 Aug 14, 2018	SELL	$26.4 - $42.0 $660,712 - $1.05 Million	-25,027 Reduced 6.46%	362,476 $14.1 Million
Q1 2018 May 15, 2018	BUY	$18.43 - $28.8 $522,453 - $816,422	28,348 Added 7.89%	387,503 $10.7 Million
Q4 2017 Feb 14, 2018	SELL	$14.8 - $18.85 $171,739 - $218,735	-11,604 Reduced 3.13%	359,155 $6.5 Million
Q3 2017 Nov 14, 2017	BUY	$14.65 - $16.85 $5.43 Million - $6.25 Million	370,759	370,759 $5.99 Million

Others Institutions Holding HRTX

# of Institutions

180

Shares Held

121M

Call Options Held

80.4K

Put Options Held

94.9K

Rubric Capital Management LP New York, NY

26.7M
Shares

$28.6 Million
1.48% of portfolio
Adage Capital Partners Gp, L.L.C. Boston, MA

8.85M
Shares

$9.47 Million
0.03% of portfolio
Vanguard Group Inc Valley Forge, PA

8.72M
Shares

$9.33 Million
0.0% of portfolio
Black Rock Inc. New York, NY

8.33M
Shares

$8.91 Million
0.0% of portfolio
Velan Capital Investment Management LP Alpharetta, GA

6.99M
Shares

$7.48 Million
28.8% of portfolio

View Full List

About HERON THERAPEUTICS, INC.

Ticker HRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,774,000
Market Cap $127M
Description
Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single a...

More about HRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Panagora Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Panagora Asset Management Inc with notifications on news.

Account